Positive screening and carrier results for the England-wide universal newborn sickle cell screening programme by

Allison Streetly1, Radoslav Latinovic, Joan Henthorn

  • 1NHS Sickle Cell and Thalassaemia Screening Programme, King's College London School of Medicine, Division of Health and Social Care Research, London, UK. allison.streetly@kcl.ac.uk

Insights

Newborn screening in England identified sickle cell disease (SCD) at a prevalence of 1:2000, with significant ethnic and geographic variations. Early detection through this national program aims to reduce complications and deaths in at-risk infants.

Area of Science:

  • Public Health
  • Genetics
  • Neonatal Screening

Background:

  • Sickle cell disease (SCD) is a significant inherited blood disorder.
  • Early detection and intervention are crucial for minimizing mortality and morbidity.
  • A national newborn screening program was implemented to address these needs.

Purpose of the Study:

  • To identify infants at risk of sickle cell disease through universal newborn screening.
  • To establish the prevalence and distribution of SCD and related conditions in newborns across England.
  • To inform service planning and public health strategies.

Main Methods:

  • Universal newborn screening for sickle cell disease was conducted in England from September 2003 to July 2006.
  • Dried bloodspot cards were utilized across 13 newborn laboratories.
  • Screening covered sickle cell anaemia (Hb SS), Hb SC disease, Hb S/beta thalassaemia, Hb S/D(Punjab), and Hb S/O(Arab).

Main Results:

  • The overall prevalence of screen-positive results was 1:2000.
  • A 25-fold variation in prevalence was observed across geographical areas.
  • African infants accounted for 61% of screen-positive results, with carrier rates up to 1:7 in this group, compared to 1:540 in 'White British' infants.

Conclusions:

  • The study provides crucial data on the frequency and distribution of sickle cell disease and carrier states in England.
  • Findings highlight significant ethnic and geographic disparities in disease prevalence.
  • Results can guide the refinement of genetic counseling, targeted services, and public health information campaigns.
Abstract

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Test for Homogeneity01:23

Test for Homogeneity

The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...